DIALYSIS · CCN 492573

DaVita Front Royal Dialysis

FRONT ROYAL, VA 22630

DialysisProfitDaVita
$5.1M
TOTAL REVENUE
42.8%
OPERATING MARGIN
3 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$5.1M
Total costs
$2.9M
Operating income (rev − costs)
$2.2M
Operating margin
42.8%
Total charges
$5.1M
Total treatments
10,794
Dialysis stations
16

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.2869—
Fistula Rate
DFC_FISTULA_RATE
6665—
Five Star Rating
DFC_FIVE_STAR
3——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
167.475—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1965—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
28.1292—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
9.868—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
30.471—
Standardized ED Visits Ratio
DFC_SEDR
1.0434—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
30.229—